First-In-Human Phase I Study of a Next-Generation, Oral, TGF b Receptor 1 Inhibitor, LY3200882, in Patients with Advanced Cancer
暂无分享，去创建一个
W. Mason | D. Melisi | S. Estrem | T. Yap | L. Gandhi | M. Man | A. Cervantes | A. Carpentier | V. Atkinson | S. Kondo | S. Callies | M. Simonelli | J. Manuel | S. Ochsenreither | R. Redman | Yumin Zhao | Emin Avşar | C. Baldini | M. Vieito | A. Westhuizen | E. Rhun | R. Cosman | Louise Warren | E. Avşar | Rasha Cosman